Novo Nordisk has innovative prescription for expansion
The world’s largest insulin producer, Novo Nordisk A/S, said it would not pursue mergers and acquisitions (M&A) in China but would instead expand by strengthening its research and development (R&D) …
Novo Nordisk has innovative prescription for expansion Read More
